Sort by
Refine Your Search
-
Category
-
Country
-
Field
-
Details Posted: Unknown Location: Salary: Summary: Summary here. Details Posted: 15-Jul-25 Location: Irvine, California Type: Postdoc Categories: Academic/Faculty Medical - Research Internal Number
-
Research Environment You will be part of the research group led by Assoc. Prof. Rasmus Siersbæk (Siersbaek group ) at the Dept. of Biochemistry and Molecular Biology (BMB) at SDU. The Siersbæk group is part
-
complexes. Nat Commun. 9(1):2311. Lab and Research Environment You will be part of the research group led by Assoc. Prof. Rasmus Siersbæk (Siersbaek group ) at the Dept. of Biochemistry and Molecular Biology
-
professor, one assistant professor, one postdoc, and a large number of PhD students. The project includes strong partnerships with the University of Leipzig (Bioinformatics, Prof. Peter Stadler
-
students and 200 postdocs will be part of the Research School. The DDLS program has four strategic research areas: cell and molecular biology, evolution and biodiversity, precision medicine and diagnostics
-
, such as molecular data (e.g. omics), imaging, electronic health care records, longitudinal patient and population registries and biobanks. To be a doctoral student means to devote oneself to a research
-
than 260 PhD students and 200 postdocs will be part of the Research School. The DDLS program has four strategic research areas: cell and molecular biology, evolution and biodiversity, precision medicine and
-
postdocs will be part of the Research School. The DDLS program has four strategic research areas: cell and molecular biology, evolution and biodiversity, precision medicine and diagnostics, epidemiology and
-
The main focus of the Collaborative Research Centre (CRC) 1123 Atherosclerosis – Mechanisms and Networks of Novel Therapeutic Targets is to study in depth the molecular networks in atherogenesis
-
Signals in Cancer” (Head: Prof. Dr. med. Jürgen Ruland) is to (i) explore the molecular mechanisms and pathways that drive immune dysfunction and immunotherapy resistance, (ii) modulate cancer